OpenAlex
PricingAboutJobs
Log inGet started
Work

Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Adult Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts)

HTML

Year: 2013
Type: conference-abstract
Source: ORBi (University of Liège)
Authors: Fakhouri, Fadi, Hourmant, Maryvonne, Campistol, Josep, Cataland, Spero, Espinosa, Mario, Gaber, Osama, Menne, Jan, Minetti, Enrico, Provot, François, Rondeau, Eric, Ruggenenti, Piero, WEEKERS, Laurent, Ogawa, Masayo, Bedrosian, Camille, Legendre, Christophe
Institutions: Hôpital Necker-Enfants Malades, Centre Hospitalier Universitaire de Nantes, The Ohio State University, Hospital Universitario Reina Sofía, Houston Methodist, Medizinische Hochschule Hannover, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Centre Hospitalier Universitaire de Lille, Assistance Publique – Hôpitaux de Paris, Hôpital Tenon, Mario Negri Institute for Pharmacological Research, Centre Hospitalier Universitaire de Liège, Alexion Pharmaceuticals (United States), Université Paris Descartes
Language: English

Topic: Complement system in diseases
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: eculizumab, atypical hemolytic uremic syndrome, thrombotic microangiopathy, renal function, complement inhibition, adult patients
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W1908862090
Cites:
Cited by: 11
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms